Cannabis Briefing

Medical cannabis is already an evidence-based therapy firmly established for conditions such as chronic pain and spasticity. Of course, additional…

As Germany’s new federal government continues to organize itself, it's worth looking across the border. Elsewhere in Europe, things are moving — not…

A year ago, Germany’s new cannabis law came into effect—more than just a so-called “legalization.” It marked the decriminalization of recreational…

Last week, the German Pain and Palliative Care Days 2025 took place in Frankfurt. Among the numerous lectures and workshops, the use of cannabinoids…

The Endocannabinoid System (ECS) is one of the most fascinating yet least understood systems in the human body. It regulates numerous physiological…

Which cannabis events should you not miss in 2025? From ICBC Berlin and Spannabis to MJBizCon in Las Vegas – get an overview of the most important…

A Step Forward: Easier Access to Medical Cannabis Since the legal changes in spring 2024, medical cannabis can now be prescribed with significantly…

Cannabis research in Germany: Discover why cannabis studies are crucial, which cities are participating, and how scientific data paves the way for…

The year 2024 has been a milestone for the cannabis industry in Germany. The removal of medical cannabis from the Narcotics Act and the launch of…

Is Germany's medical cannabis market booming or heading toward consolidation? Discover the latest Cannabis Briefing for insights into the…

Cansativa’s "Yes, We Can Cannabizz" event in Berlin brought together industry leaders, medical experts, and patients to discuss the future of…

Research lies at the heart of advancements in cannabis and medical cannabis. Thorough scientific studies not only enhance therapeutic understanding…

In today’s Cannabis Briefing, we look beyond our usual scope and explain why the US elections hold international significance, particularly for…

Last year, Switzerland launched its first pilot projects to study the recreational use of cannabis. In today’s edition of the Cannabis Briefing, we…

While Germany has taken the bold step of decriminalizing cannabis for recreational purposes, signaling a major shift in European drug policy, its…

Excitement is widespread in the medical cannabis community and among patients. On July 18, the Federal Joint Committee (Gemeinsamer Bundesausschuss…

It's been 100 days since cannabis was decriminalized in Germany, and the landscape is evolving rapidly. As of this month, cultivation clubs in…

In this edition of our Cannabis Briefing, we explore a development that promises to reshape the landscape of medical cannabis across Europe—not…

In today’s edition of The Cannabis Briefing, we delve deeper into the current challenges and developments in the realm of medicinal cannabis. We had…

As summer draws near, the season of events is just beginning. Continuing our tradition from the last two years, this issue highlights a selection of…

Our readers are well-versed in the societal discourse surrounding cannabis and its legal frameworks. The emotional intensity of the debate persists,…

The recently enacted Cannabis Law marks a significant milestone in German drug policy. However, as soon as the law was passed, the focus swiftly…

After an intensive legislative process, the first Cannabis Act is facing its last major hurdle: vote in the Bundesrat (Federal Council) on March…

After an intensive legislative process, the first Cannabis Act is facing its last major hurdle: vote in the Bundesrat (Federal Council) on March…

After an intensive legislative process, the first Cannabis Act is facing its last major hurdle: vote in the Bundesrat (Federal Council) on March…

Medical cannabis is often used in patients with pain when other therapy options are no longer effective. This is frequently the case with chronic…